Nuwellis, Inc. (NUWE)

Market Cap	2.71M -37.9%
Revenue (ttm)	8.27M -5.4%
Net Income	-17.52M
EPS	-25.38
Shares Out	2.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,689
Open	1.060
Previous Close	1.040
Day's Range	0.995 - 1.060
52-Week Range	0.960 - 43.260
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About NUWE

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Au...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 38
• Stock Exchange: NASDAQ
• Ticker Symbol: NUWE
• Website: https://www.nuwellis.com

Financial Performance

In 2025, Nuwellis's revenue was $8.27 million, a decrease of -5.38% compared to the previous year's $8.74 million. Losses were -$17.52 million, 64.9% more than in 2024.